Oncology & Cancer

Promising new research on aggressive breast cancer

Better treatments of HER2-positive breast cancer are closer at hand, thanks to new research by a team led by Université de Montréal professor Jean-François Côté at the cytoskeleton organization and cell-migration research ...

Oncology & Cancer

Tissue stiffness linked to aggressive type of breast cancer

(Medical Xpress)—A new study has linked the stiffness of breast tissue to the progression of a particularly aggressive form of breast cancer. Published in Nature Medicine this month, the study may help clinicians differentiate ...

Oncology & Cancer

Study links another gene variant to male breast cancer

(HealthDay)—Researchers report that they've identified another genetic variation that appears connected to male breast cancer, a rare condition that kills several hundred men in the United States each year.

Oncology & Cancer

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Oncology & Cancer

New point of attack for breast cancer with poor prognosis

(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report in the latest issue of Nature ...

page 1 from 9